KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Interest Coverage Ratio (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Interest Coverage Ratio for 8 consecutive years, with 159.46 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio fell 462.23% to 159.46 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 497.79 through Dec 2025, down 3091.34% year-over-year, with the annual reading at 497.79 for FY2025, 3412.86% down from the prior year.
  • Interest Coverage Ratio hit 159.46 in Q4 2025 for Castle Biosciences, up from 283.5 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 44.02 in Q4 2024 to a low of 15171.0 in Q4 2021.
  • Historically, Interest Coverage Ratio has averaged 3462.74 across 5 years, with a median of 1642.82 in 2025.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 197543.3% in 2021 and later surged 101.56% in 2024.
  • Year by year, Interest Coverage Ratio stood at 15171.0 in 2021, then surged by 62.38% to 5708.0 in 2022, then soared by 50.44% to 2829.0 in 2023, then soared by 101.56% to 44.02 in 2024, then plummeted by 462.23% to 159.46 in 2025.
  • Business Quant data shows Interest Coverage Ratio for CSTL at 159.46 in Q4 2025, 283.5 in Q3 2025, and 202.43 in Q2 2025.